52471-07-5 Usage
Uses
Used in Pharmaceutical Synthesis:
2-Amino-6-chloronicotinonitrile is utilized as an intermediate in the synthesis of pharmaceuticals, contributing to the development of new drugs for various diseases. Its unique functional groups facilitate the creation of diverse bioactive molecules, enhancing the scope of available treatments.
Used in Agrochemical Production:
In the agrochemical industry, 2-Amino-6-chloronicotinonitrile serves as a key intermediate, playing a crucial role in the synthesis of various agrochemicals. Its properties allow for the development of effective compounds for crop protection and other agricultural applications.
Used in Medicinal Chemistry Research:
2-Amino-6-chloronicotinonitrile is employed as a valuable building block in medicinal chemistry, where it is used to explore and develop novel drug candidates. Its versatility in organic synthesis makes it instrumental in the advancement of drug discovery research.
Used in Drug Discovery Research:
As a compound with potential pharmacological applications, 2-Amino-6-chloronicotinonitrile is used in drug discovery research to identify and optimize new therapeutic agents. Its presence as a precursor to bioactive molecules makes it a significant component in the search for innovative treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 52471-07-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,4,7 and 1 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 52471-07:
(7*5)+(6*2)+(5*4)+(4*7)+(3*1)+(2*0)+(1*7)=105
105 % 10 = 5
So 52471-07-5 is a valid CAS Registry Number.
52471-07-5Relevant articles and documents
URACIL DERIVATIVES AS MER-AXL INHIBITORS
-
Page/Page column 120, (2019/11/19)
The invention relates generally to compounds that are Mer-Axl inhibitors, pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and disorders of dysregulated apoptosis, such as cancer, utilizing the compounds of the invention.
THERAPEUTIC INHIBITORY COMPOUNDS
-
, (2019/01/08)
Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds which are complement factor D inhibitors. Such compounds are useful for treating complement related disorders including, but are not limited to, autoimmune, inflammatory, and neurodegenerative diseases.
THERAPEUTIC INHIBITORY COMPOUNDS
-
, (2017/07/04)
Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds which are complement factor D inhibitors. Such compounds are useful for treating complement related disorders including, but are not limited to, autoimmune, inflammatory, and neurodegenerative diseases.